apollo
logo
0Login
Introducing Our Latest Arrival!
TagSita 50 Tablet 7's

TagSita 50 Tablet 7's

Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

Goldine Pharmaceutical Pvt Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Apr-26

for this medicine

About TagSita 50 Tablet

TagSita 50 Tablet is used to treat type-2 diabetes mellitus. Type-2 diabetes mellitus (also known as non-insulin-dependent diabetes or adult-onset diabetes) is a medical condition in which blood glucose levels are above normal due to insulin deficiency, insulin resistance, or both.

TagSita 50 Tablet contains Dapagliflozin (sodium-glucose cotransporter-2 inhibitors) and Sitagliptin (dipeptidyl peptidase-4 inhibitor). Dapagliflozin lowers blood glucose levels and increases the excretion of glucose in the urine. By increasing insulin levels and lowering glucagon levels (the hormone that raises blood glucose levels), sitagliptin decreases the amount of glucose the liver produces. Thus, TagSita 50 Tablet helps control blood sugar levels.

TagSita 50 Tablet may cause side effects such as diarrhoea, hypoglycaemia, headache, nausea, and vomiting. These effects do not require medical attention and gradually resolve over time. Inform your doctor if any of these side effects persist or bother you. Take TagSita 50 Tablet as prescribed by your doctor.

TagSita 50 Tablet should be avoided if you are allergic to any of the components in it. Inform your doctor if you are pregnant or breastfeeding. Let your doctor know about all the medicines you are taking and your health condition to rule out any unpleasant side effects/interactions.

Uses of TagSita 50 Tablet

Treatment of Type-2 diabetes mellitus

Medicinal Benefits

TagSita 50 Tablet is a combination medicine containing Dapagliflozin and Linagliptin as active ingredients. Dapagliflozin helps in removing excess sugar from the body via urine. Linagliptin works by decreasing the hormones that raise blood glucose levels and increasing insulin release from the pancreas. Together, TagSita 50 Tablet helps control blood sugar levels.

Directions for Use

Take TagSita 50 Tablet with or after food. Swallow TagSita 50 Tablet as a whole with a glass of water; do not break, chew or crush it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of TagSita 50 Tablet

  • Stomach upset
  • Hypoglycaemia (low blood sugar levels)
  • Nausea
  • Vomiting
  • Diarrhea
  • Headache
  • Constipation
  • Dizziness
  • Runny nose
  • Sore throat

Drug Warnings

Do not take TagSita 50 Tablet if you are allergic to any of its components. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects. Inform your doctor if you have any liver/kidney disease, heart problems, and hypertension before taking TagSita 50 Tablet. TagSita 50 Tablet is not recommended for children as safety and effectiveness have not been established. Avoid alcohol consumption while taking TagSita 50 Tablet as it might cause unpleasant side effects. It is unknown whether TagSita 50 Tablet can be given to pregnant women or breastfeeding mothers. Hence, inform your doctor if you are pregnant or breastfeeding. It is not recommended for use in children below 18 years of age.

Drug Interactions

Drug-Drug Interactions: TagSita 50 Tablet may interact with anti-diabetic (insulin glargine), diuretics (furosemide), hormone (levothyroxine) and corticosteroids.

Drug-Food Interactions: Avoid alcohol consumption.

Drug-Disease Interactions: Inform your doctor if you have hypoglycaemia (low blood sugar levels), heart problems and liver/kidney disease.

Drug-Drug Interactions Checker List

  • INSULIN
  • FUROSEMIDE
  • LEVOTHYROXINE

Habit Forming

No

Diet & Lifestyle Advise

  • Eat foods rich in healthy carbohydrates and fibre, fruits, whole grains, and vegetables.
  • Try eating food at regular intervals. Do not skip meals. Also, try not to overeat.
  • Follow a healthy diet and walk/exercise for at least 45 minutes.
  • Maintain a healthy weight by exercising regularly.
  • Rest properly and avoid stress by doing meditation or yoga.

Special Advise

  • Regularly monitor blood glucose levels while taking TagSita 50 Tablet.
  • Try not to skip any doses and take TagSita 50 Tablet for as long as your doctor has prescribed it for you.
  • Always carry a sugary food such as candy or fruit juice and consume them if you experience hypoglycaemia.

Disease/Condition Glossary

Type-2 diabetes mellitus: It is also known as non-insulin-dependent diabetes. It is a chronic or lifelong disease that keeps the body from utilizing insulin properly. Diabetes is a medical condition in which blood glucose levels are above normal. People with type 2 diabetes either do not produce enough insulin, or the produced insulin cannot perform its function in the body (insulin resistance).

bannner image

Alcohol

Unsafe

Avoid consumption of alcohol during treatment with TagSita 50 Tablet as it may cause serious side effects.

bannner image

Pregnancy

Consult your doctor

If you are pregnant or planning pregnancy, inform your doctor before starting treatment with TagSita 50 Tablet. Your doctor may prescribe this medicine if the benefits outweigh the risks.

bannner image

Breast Feeding

Consult your doctor

Limited data is available on the effect of TagSita 50 Tablet on breastfeeding. Hence, if you are a nursing mother, inform your doctor before taking TagSita 50 Tablet. Your doctor may prescribe this medicine if the benefits outweigh the risks.

bannner image

Driving

Caution

TagSita 50 Tablet may occasionally cause dizziness. Hence, drive only if you are alert after taking this medicine.

bannner image

Liver

Consult your doctor

If you have a pre-existing or a history of liver disease, inform your doctor before taking TagSita 50 Tablet. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

bannner image

Kidney

Consult your doctor

If you have a pre-existing or a history of kidney disease, inform your doctor before taking TagSita 50 Tablet. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

bannner image

Children

Unsafe

TagSita 50 Tablet is not recommended for use in children below 12 years of age as the safety and efficacy are not established.

Country of origin

India
Other Info - TAG0045

FAQs

TagSita 50 Tablet is used to treat type-2 diabetes mellitus. Type-2 diabetes mellitus (also known as non-insulin-dependent diabetes or adult-onset diabetes) is a medical condition in which blood glucose levels are above normal due to insulin deficiency, insulin resistance, or both.
Low-fibre diets, high-fat diets, sugary diets, obesity, smoking, stress, lack of exercise, age, genetic factors, and certain medical conditions are the common causes of diabetes.
TagSita 50 Tablet is a combination medicine containing Sitagliptin that enhances glucose-mediated insulin secretion, thereby reducing fasting and post-prandial blood sugar concentrations. Dapagliflozin lowers blood glucose levels and increases the excretion of glucose in the urine. By increasing insulin levels and lowering glucagon levels (the hormone that raises blood glucose levels), sitagliptin decreases the amount of glucose the liver produces.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.